Introduction to The Olivieri symposium.
D026688:Bioethical Issues; D001803:Blood Transfusion; D002170:Canada; D002986:Clinical Trials as Topic / Q000941:ethics*; D000077543:Deferiprone; D004345:Drug Industry / Q000941:ethics; D017007:Duty to Warn; D032984:Ethics, Research; D006801:Humans; D007258:Informed Consent; D007373:Interinstitutional Relations; D007502:Iron Chelating Agents / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000139:chemically induced; D011728:Pyridones / Q000009:adverse effects*; D012109:Research Support as Topic / Q000941:ethics*; D014495:Universities / Q000941:ethics*; D035642:Whistleblowing / Q000941:ethics; D017086:beta-Thalassemia / Q000188:drug therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone
Apotex; Biomedical and Behavioral Research; Hospital for Sick Children (Toronto); University of Toronto